In a report released today, Chase Knickerbocker from Craig-Hallum reiterated a Buy rating on Indivior (INDV – Research Report). The company’s shares opened today at p956.00.
According to TipRanks, Knickerbocker is a 4-star analyst with an average return of 6.9% and a 55.34% success rate. Knickerbocker covers the Healthcare sector, focusing on stocks such as Harrow Health, Xeris Pharmaceuticals, and Eton Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Indivior with a p1,926.68 average price target, representing a 101.54% upside. In a report released today, Stifel Nicolaus also reiterated a Buy rating on the stock with a p2,500.00 price target.
The company has a one-year high of p1,927.00 and a one-year low of p653.00. Currently, Indivior has an average volume of 771.3K.
Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of INDV in relation to earlier this year.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Indivior (INDV) Company Description:
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior’s revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
ncG1vNJzZmilkae4psDSZ5muq5mjsrS%2FyKeqopyVp3uku8xopZ6vo2TAtbvCpKpom6KWtqh5x5qjpa2dYrimsc%2BsZK2glZ6%2Fbq7UsmSrmaSeu6h5zqdkoqaUnsOqu9FmoKecpmJ%2BcX%2BSbnBub2ll